Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Encouraging innovation will allow physicians and their academic medical centers to pursue the development of technologies and healthcare practices that will improve patient care.
Novel beneficial traits in agricultural microbes represent inventive steps of nature, but the inability of patent laws to reward nonhuman inventors has led to conflicts over microbial ownership rights and presents barriers to the sharing of benefits.
Decentralized autonomous organizations are growing as alternative research funding models, but are also strong scientific communities. We should get on board.
Some 700 approved therapies in the United States — roughly a third of all drugs on the market — target G-protein-coupled receptors (GPCRs). Now advances in high-throughput and structure-based screening are sparking a second golden age of GPCR-based drug discovery.